W. Norman Thornton Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Virginia Health System, Charlottesville, VA 22908, USA.
Neoplasia. 2011 Oct;13(10):899-911. doi: 10.1593/neo.11138.
Although controversial, recent studies suggest that serous ovarian carcinomas may arise from fallopian tube fimbria rather than ovarian surface epithelium. We developed an in vitro model for serous carcinogenesis in which primary human fallopian tube epithelial cells (FTECs) were exposed to potentially oncogenic molecular alterations delivered by retroviral vectors. To more closely mirror in vivo conditions, transformation of FTECs was driven by the positive selection of growth-promoting alterations rather antibiotic selection. Injection of the transformed FTEC lines in SCID mice resulted in xenografts with histologic and immunohistochemical features indistinguishable from poorly differentiated serous carcinomas. Transcriptional profiling revealed high similarity among the transformed and control FTEC lines and patient-derived serous ovarian carcinoma cells and was used to define a malignancy-related transcriptional signature. Oncogene-treated FTEC lines were serially analyzed using quantitative reverse transcription-polymerase chain reaction and immunoblot analysis to identify oncogenes whose expression was subject to positive selection. The combination of p53 and Rb inactivation (mediated by SV40 T antigen), hTERT expression, and oncogenic C-MYC and HRAS accumulation showed positive selection during transformation. Knockdown of each of these selected components resulted in significant growth inhibition of the transformed cell lines that correlated with p27 accumulation. The combination of SV40 T antigen and hTERT expression resulted in immortalized cells that were nontumorigenic in mice, whereas forced expression of a dominant-negative p53 isoform (p53DD) and hTERT resulted in senescence. Thus, our investigation supports the tubal origin of serous carcinoma and provides a dynamic model for studying early molecular alterations in serous carcinogenesis.
尽管存在争议,但最近的研究表明,浆液性卵巢癌可能起源于输卵管伞而非卵巢表面上皮。我们开发了一种浆液性癌发生的体外模型,其中原代人输卵管上皮细胞(FTEC)暴露于逆转录病毒载体传递的潜在致癌分子改变。为了更接近体内条件,FTEC 的转化由促进生长的改变的正选择驱动,而不是抗生素选择。将转化的 FTEC 系注射到 SCID 小鼠中,导致异种移植物具有与低分化浆液性癌无法区分的组织学和免疫组织化学特征。转录谱分析显示,转化和对照 FTEC 系以及患者来源的浆液性卵巢癌细胞之间具有高度相似性,并用于定义与恶性肿瘤相关的转录特征。使用定量逆转录聚合酶链反应和免疫印迹分析对经处理的癌基因 FTEC 系进行连续分析,以鉴定表达受正选择的癌基因。p53 和 Rb 失活(由 SV40 T 抗原介导)、hTERT 表达以及致癌 C-MYC 和 HRAS 积累的组合在转化过程中显示出正选择。这些选定成分中的每一个的敲低都会导致转化细胞系的显著生长抑制,这与 p27 积累相关。SV40 T 抗原和 hTERT 表达的组合导致永生化细胞,而在小鼠中这些细胞无致瘤性,而强制表达显性负 p53 同工型(p53DD)和 hTERT 则导致衰老。因此,我们的研究支持浆液性癌的输卵管起源,并提供了研究浆液性癌发生早期分子改变的动态模型。